Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
amgen
biotech
clinical trials
eli lilly
life sciences
national blog main
calcitonin gene-related peptide
indiana blog main
indiana top stories
migraine
national
national top stories
new york blog main
teva pharmaceutical
allergan
biohaven
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
chronic migraine
detroit blog main
detroit top stories
drugs
episodic migraine
eptinezumab
erenumab
food and drug administration
fremanezumab
galcanezumab
medical device
migraine research foundation
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
What
class
5
×
fda
5
×
migraine
new
approval
drug
medicines
won
approved
developed
gets
nod
pain
starts
adults
allergan
amgen
announced
application
arguments
autism
big
candidates
clearance
cognoa
cognoa’s
commercialized
companies
competitors
decades
decision
device
diagnosis
diagnostic
digital
drugs
eli
gained
head
headache
Language
unset
Current search:
class
×
fda
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@techcrunch.com
6 years ago
Cognoa’s AI platform for autism diagnosis gets first FDA stamp